Sulfation of melatonin: Enzymatic characterization, differences of organs, species and genders, and bioactivity variation

Biochemical Pharmacology

Volumn 94, Issue 4, 2015, Pages 282-296

  Tian, Xiangge ^a   Huo, Xiaokui ^a   Dong, Peipei ^a   Wu, Baojian ^b   Wang, Xiaobo ^a,c   Wang, Chao ^a   Liu, Kexin ^a   Ma, Xiaochi ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

^c The 210th Hospital of PLA   (China)

Author keywords

Anti inflammatory; Genders; Melatonin; Species differences; Sulfation

Indexed keywords

ANTIINFLAMMATORY AGENT; ARYL SULFOTRANSFERASE; ISOENZYME; MELATONIN; NITRIC OXIDE; SULT1A1 PROTEIN, HUMAN;

ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CELL LINE; CHEMISTRY; DOG; FEMALE; HAPLORHINI; HUMAN; MALE; METABOLISM; MOLECULAR DOCKING; MOUSE; PIG; RAT; SPECIES DIFFERENCE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARYLSULFOTRANSFERASE; CELL LINE; DOGS; FEMALE; HAPLORHINI; HUMANS; ISOENZYMES; MALE; MELATONIN; MICE; MOLECULAR DOCKING SIMULATION; NITRIC OXIDE; ORGAN SPECIFICITY; RATS; SPECIES SPECIFICITY; SWINE;

EID: 84929939475     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2015.02.010     Document Type: Article

References (49)

1. E.B. Yalcin, V. More, K.L. Neira, Z.J. Lu, N.J. Cherrington, and A.L. Slitt Down regulation of sulfotransferase expression and activity in diseased human livers Drug Metab. Dispos. 41 2013 1642 1650
2. F.C. Kauffman Sulfonation in pharmacology and toxicology Drug Metab. Rev. 36 2004 823 843
3. S. Nowell, and C.N. Falany Pharmacogenetics and human cytosolic sulfotransferases Oncogene 25 2006 1673 1678
4. R.L. Blanchard, R.R. Freimuth, J. Buck, R.M. Weinshilboum, and M.W. Coughtrie A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily Pharmacogenetics 14 2004 199 211
5. Z. Riches, E.L. Stanley, J.C. Bloomer, and M.W. Coughtrie Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: the SULT pie. Riches Z, Stanley EL, Bloomer JC, Coughtrie MW Drug Metab. Dispos. 37 2009 2255 2261
6. W. Honma, Y. Kamiyama, K. Yoshinari, H. Sasano, M. Shimada, and K. Nagata Enzymatic characterization and interspecies difference of phenol sulfotransferases, ST1A forms Drug Metab. Dispos. 29 2001 274 281
7. M. Kojima, and M. Degawa Sex differences in the constitutive gene expression of sulfotransferases and UDP-glucuronosyltransferases in the pig liver: androgen-mediated regulation Drug Metab. Pharmacokinet. 29 2014 192 197
8. E. Maronde, A. Saade, K. Ackermann, H. Goubran-Botros, C. Pagan, and R. Bux Dynamics in enzymatic protein complexes offer a novel principle for the regulation of melatonin synthesis in the human pineal gland J. Pineal Res. 51 2011 145 155
9. G.A. Bubenik Gastrointestinal melatonin: localization, function, and clinical relevance Dig. Dis. Sci. 47 2002 2336 2348
10. A. Carrillo-Vico, J.M. Guerrero, P.J. Lardone, and R.J. Reiter A review of the multiple actions of melatonin on the immune system Endocrine 27 2005 189 200
11. D.X. Tan, L.C. Manchester, R. Hardeland, S. Lopez-Burillo, J.C. Mayo, and R.M. Sainz Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin J. Pineal Res. 34 2003 75 78
12. H. Tamura, A. Takasaki, T. Taketani, M. Tanabe, F. Kizuka, and L. Lee The role of melatonin as an antioxidant in the follicle J. Ovarian Res. 5 2012 5
13. H. Aly, H. Elmahdy, M. El-Dib, M. Rowisha, M. Awny, and T. El-Gohary Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study J. Perinatol. 2014 10.1038/jp.2014.186
14. 3 synergistically down-regulate Akt and MDM2 leading to TGFβ-1-dependent growth inhibition of breast cancer cells J. Pineal Res. 50 2011 150 158
15. A.A. Zamfir Chiru, C.R. Popescu, and D.C. Gheorghe Melatonin and cancer J. Med. Life 7 2014 373 374
16. K. Gulle, M. Akpolat, Z. Kurcer, M.I. Cengiz, F. Baba, and S. Acikgoz Multi-organ injuries caused by lipopolysaccharide-induced periodontal inflammation in rats: role of melatonin J. Periodontal Res. 49 2014 736 741
17. C. Phiphatwatcharaded, A. Topark-Ngarm, P. Puthongking, and P. Mahakunakorn Anti-inflammatory activities of melatonin derivatives in lipopolysaccharide-stimulated RAW 264.7 cells and antinociceptive effects in mice Drug Dev. Res. 75 2014 235 245
18. W.G. Deng, S.T. Tang, H.P. Tseng, and K.K. Wu Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding Blood 108 2006 518 524
19. R.B. Costello, C.V. Lentino, C.C. Boyd, M.L. O'Connell, C.C. Crawford, and M.L. Sprengel The effectiveness of melatonin for promoting healthy sleep: a rapid evidence assessment of the literature Nutr. J. 13 2014 106
20. M.V. Hansen, A.K. Danielsen, I. Hageman, J. Rosenberg, and I. Gögenur The therapeutic or prophylactic effect of exogenous melatonin against depression and depressive symptoms: a systematic review and meta-analysis Eur. Neuropsychopharmacol. 24 2014 1719 1728
21. Y. Yang, Y. Sun, W. Yi, Y. Li, C. Fan, and Z. Xin A review of melatonin as a suitable antioxidant against myocardial ischemia-reperfusion injury and clinical heart diseases J. Pineal Res. 57 2014 357 366
22. S. Härtter, S. Morita, K. Bodin, C. Ursing, G. Tybring, and L. Bertilsson Determination of exogenous melatonin and its 6-hydroxy metabolite in human plasma by liquid chromatography-mass spectrometry Ther. Drug Monit. 23 3 2001 282 286
23. C. Li, G. Li, D.X. Tan, F. Li, and X. Ma A novel enzyme-dependent melatonin metabolite in humans J. Pineal Res. 54 2013 100 106
24. A. Cavallo, and L.M. Dolan 6-Hydroxymelatonin sulfate excretion in human puberty J. Pineal Res. 21 1996 225 230
25. B. Griefahn, P. Bröde, M. Blaszkewicz, and T. Remer Melatonin production during childhood and adolescence: a longitudinal study on the excretion of urinary 6-hydroxymelatonin sulfate J. Pineal Res. 34 2003 26 31
26. T.K. Kim, K. Kleszczynski, Z. Janjetovic, T. Sweatman, Z. Lin, and W. Li Metabolism of melatonin and biological activity of intermediates of melatoninergic pathway in human skin cells FASEB J. 27 2013 2742 2755
27. S. Aust, W. Jaeger, M. Klimpfinger, K. Mayer, G. Baravalle, and C. Ekmekcioglu Biotransformation of melatonin in human breast cancer cell lines: role of sulfotransferase 1A1 J. Pineal Res. 39 2005 276 282
28. E.S. Schernhammer, F. Berrino, V. Krogh, G. Secreto, A. Micheli, and E. Venturelli Urinary 6-sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort Cancer Epidemiol. Biomarkers Prev. 19 2010 729 737
29. M. Basler, A. Jetter, D. Fink, B. Seifert, G.A. Kullak-Ublick, and A. Trojan Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literature Breast Care 9 2014 182 187
30. X. Diao, X. Pang, C. Xie, Z. Guo, D. Zhong, and X. Chen Bioactivation of 3-n-butylphthalide via sulfation of its major metabolite 3-hydroxy-NBP: mediated mainly by sulfotransferase 1A1 Drug Metab. Dispos. 42 2014 774 781
31. M. Minami, H. Takahashi, H. Inagaki, Y. Yamano, S. Onoue, and S. Matsumoto Novel tryptamine-related substances, 5-sulphatoxydiacetyltryptamine, 5-hydroxydiacetyltryptamine, and reduced melatonin in human urine and the determination of those compounds, 6-sulphatoxymelatonin, and melatonin with fluorometric HPLC J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 877 2009 814 822
32. R.S. King, A.A. Ghosh, and J. Wu Inhibition of human phenol and estrogen sulfotransferase by certain non-steroidal anti-inflammatory agents Curr. Drug Metab. 7 2006 745 753
33. G.M. Pacifici Inhibition of human liver and duodenum sulfotransferases by drugs and dietary chemicals: a review of the literature Int. J. Clin. Pharmacol. Ther. 42 2004 488 495
34. L. Wang, N. Raghavan, K. He, J.M. Luettgen, W.G. Humphreys, and R.M. Knabb Sulfation of o-demethylapixaban: enzyme identification and species comparison Drug Metab. Dispos. 37 2009 802 808
35. J.M. Hutzler, and T.S. Tracy Atypical kinetic profiles in drug metabolism reactions Drug Metab. Dispos. 30 2002 355 362
36. K. Ko, K. Kurogi, G. Davidson, M.Y. Liu, Y. Sakakibara, and M. Suiko Sulfation of ractopamine and salbutamol by the human cytosolic sulfotransferases J. Biochem. 152 2012 275 283
37. C.A. Tabrett, and M.W. Coughtrie Phenol sulfotransferase 1A1 activity in human liver: kinetic properties, interindividual variation and re-evaluation of the suitability of 4-nitrophenol as a probe substrate Biochem. Pharmacol. 66 2003 2089 2097
38. X. Tian, S. Liang, C. Wang, B. Wu, G. Ge, and S. Deng Regioselective glucuronidation of andrographolide and its major derivatives: metabolite identification, isozyme contribution, and species differences AAPS J. 2014 10.1208/s12248-014-9658-8
39. Y.S. Kang, Y.G. Kang, H.J. Park, H.J. Wee, H.O. Jang, and M.K. Bae Melatonin inhibits visfatin-induced inducible nitric oxide synthase expression and nitric oxide production in macrophages J. Pineal Res. 55 2013 294 303
40. H.L. Fideleff, H. Boquete, G. Fideleff, L. Albornoz, S. Pérez Lloret, and M. Suarez Gender-related differences in urinary 6-sulfatoxymelatonin levels in obese pubertal individuals J. Pineal Res. 40 2006 214 218
41. K. Kurogi, A. Chepak, M.T. Hanrahan, M.Y. Liu, Y. Sakakibara, and M. Suiko Sulfation of opioid drugs by human cytosolic sulfotransferases: metabolic labeling study and enzymatic analysis Eur. J. Pharm. Sci. 62 2014 40 48
42. K. Kohalmy, and R. Vrzal Regulation of phase II biotransformation enzymes by steroid hormones Curr. Drug Metab. 12 2011 104 123
43. M.O. James, and S. Ambadapadi Interactions of cytosolic sulfotransferases with xenobiotics Drug Metab. Rev. 45 2013 401 414
44. D.E. Bamber, A.A. Fryer, R.C. Strange, J.B. Elder, M. Deakin, and R. Rajagopal Phenol sulphotransferase SULT1A1∗1 genotype is associated with reduced risk of colorectal cancer Pharmacogenetics 11 2001 679 685
45. N.U. Gamage, S. Tsvetanov, R.G. Duggleby, M.E. McManus, and J.L. Martin The structure of human SULT1A1 crystallized with estradiol. An insight into active site plasticity and substrate inhibition with multi-ring substrates J. Biol. Chem. 280 2005 41482 41486
46. K.J. Rohn, I.T. Cook, T.S. Leyh, S.A. Kadlubar, and C.N. Falany Potent inhibition of human sulfotransferase 1A1 by 17α-ethinylestradiol: role of 3'-phosphoadenosine 5'-phosphosulfate binding and structural rearrangements in regulating inhibition and activity Drug Metab. Dispos. 40 2012 1588 1595
47. N.U. Gamage, R.G. Duggleby, A.C. Barnett, M. Tresillian, C.F. Latham, and N.E. Liyou Structure of a human carcinogen- converting enzyme, SULT1A1. Structural and kinetic implications of substrate inhibition J. Biol. Chem. 278 2003 7655 7662
48. W. Liu, L. Tang, L. Ye, Z. Cai, B. Xia, and J. Zhang Species and gender differences affect the metabolism of emodin via glucuronidation AAPS J. 12 2010 424 436
49. L. Zhang, H.Q. Zhang, X.Y. Liang, H.F. Zhang, T. Zhang, and F.E. Liu Melatonin ameliorates cognitive impairment induced by sleep deprivation in rats: role of oxidative stress, BDNF and CaMKII Behav. Brain Res. 256 2013 72 81